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The properties of the human macrophage galactose recep-
tor have been investigated. Speciﬁcity for N-acetylgalacto-
samine (GalNAc) residues with exposed 3- and 4-hydroxyl
groups explains virtually all of the results obtained from a
recently expanded array of synthetic glycans and is con-
sistent with a model for the structure of the binding site.
This simple interaction is sufﬁcient to explain the ability of
the receptor to bind to tumor-cell glycans bearing Tn and
sialyl-Tn antigens, but not to more elaborate O-linked
glycans that predominate on normal cells. This speciﬁcity
also allows for binding of parasite glycans and screening
of an array of bacterial outer membrane oligosaccharides
conﬁrms that the receptor binds to a subset of these struc-
tures with appropriately exposed GalNAc residues. A key
feature of the receptor is the clustering of binding sites in
the extracellular portion of the protein, which retains the
trimeric structure observed in the cell membrane.
Chemical crosslinking, gel ﬁltration, circular dichroism
analysis and differential scanning calorimetry demonstrate
that this trimeric structure of the receptor is stabilized by
an α-helical coiled coil that extends from the surface of the
membrane to the globular carbohydrate-recognition
domains. The helical neck domains form independent tri-
merization domains. Taken together, these results indicate
that the macrophage galactose receptor shares many of
the features of serum mannose-binding protein, in which
clusters of monosaccharide-binding sites serve as detectors
for a simple epitope that is not common on endogenous
cell surface glycans but that is abundant on the surfaces
of tumor cells and certain pathogens.
Keywords: Carbohydrate-recognition domain / Galactose
receptor / Glycan array / Glycan-binding receptor / Lectin
Introduction
Carbohydrate-binding receptors in mammals interact with
both endogenous glycans, such as those on cell surfaces and
circulating glycoproteins, and oligosaccharides and polysac-
charides on the surfaces of micro-organisms. Recognition of
endogenous glycans provides a mechanism for trafﬁcking of
glycoproteins within and between cells as well as cell–cell ad-
hesion and signaling, while binding of sugars on the surfaces
of viruses, bacteria, fungi and parasites provides a mechanism
of pathogen recognition in the innate immune system
(Robinson et al. 2006; Vasta et al. 2007; Geijtenbeek and
Gringhuis 2009). These different functions are often mediated
by structurally related receptors, many of which contain
modular carbohydrate-recognition domains (CRDs) that fall
into more than a dozen different structural families (Taylor
and Drickamer 2011). The largest and most diverse of the
families of receptors contain Ca2+-dependent CRDs that share
a common folded structure and are designated C-type CRDs
(Weis et al. 1998).
Discrimination of different sugar structures by C-type
CRDs can be viewed as occurring at multiple levels, each of
which imposes increasing speciﬁcity on the interaction. Initial
discrimination between different classes of monosaccharides
is achieved in a primary sugar-binding site that is constructed
around a conserved Ca2+-binding site, in which the orientation
of adjacent hydroxyl groups of the sugar determines the co-
ordination geometry with the Ca2+. Most binding sites involve
interaction with the 3- and 4-hydroxyl groups and bind select-
ively either to mannose-type sugars, including mannose,
glucose and GlcNAc, or to galactose-type sugars, including
galactose and GalNAc (Weis and Drickamer 1996). Further
speciﬁcity for individual monosaccharides results from local
contacts with residues near the Ca2+ site. Oligosaccharide rec-
ognition is achieved through interactions further away on the
surface of the CRD, often through bumps and protrusions that
form extended or secondary binding sites (Taylor and
Drickamer 2009).
Beyond the recognition of individual glycans through these
mechanisms, higher order speciﬁcity is often achieved by
placing multiple CRDs in groups, either as a string of CRDs†These authors contributed equally to this work.
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in a single polypeptide or as a cluster of CRDs in an oligomer
of receptor polypeptides (Dam and Brewer 2008; Coombs
et al. 2010). From the organization of the relatively few recep-
tors that have been examined in molecular detail, two general
paradigms for oligomer organization have emerged. In one
mechanism, ﬁrst described in serum mannose-binding protein,
CRDs with simple primary-binding sites that bind mannose-
type sugars are placed at a ﬁxed, wide spacing to allow high
avidity, multivalent interaction with dense arrays of mannose
and GlcNAc found on bacterial and fungal surfaces (Weis
and Drickamer 1994; Weis et al. 1998). The dendritic cell
surface receptor DC-SIGN (dendritic cell-speciﬁc intercellular
adhesion molecule-3 grabbing nonintegrin) interacts with
viral surfaces by a somewhat different mechanism, in which
mammalian-type high-mannose oligosaccharides are bound
selectively through extended-binding sites in the CRDs,
which are then ﬂexibly positioned in the receptor oligomer to
accommodate the organization of glycans on the viral surface
(Feinberg et al. 2009; Menon et al. 2009).
The macrophage galactose receptor (macrophage galactose
lectin (MGL)) is a transmembrane cell surface receptor on
macrophages and dendritic cells (Kawasaki et al. 1986;
Suzuki et al. 1996). Although MGL has been reported to bind
to a variety of galactose- and GalNAc-containing ligands,
earlier glycan array analysis suggested that the primary targets
are terminal GalNAc residues in the Tn antigen,
α-GalNAc-Ser/Thr (van Vliet et al. 2005; Napoletano et al.
2007; Saeland et al. 2007). The Tn antigen, particularly on
mucin MUC1, is associated with tumor cell surfaces (Ju et al.
2008). Binding of tumor antigens can lead to endocytosis
(Higashi et al. 2002; Napoletano et al. 2007). MGL on den-
dritic cells binding to Tn antigen is associated with antigen
presentation and regulation of activation of immune cells
(Denda-Nagai et al. 2010; Singh et al. 2011; Napoletano et al.
2012). A further target is the LacdiNAc disaccharide,
GalNAcβ1-4GlcNAc, which is abundant in parasitic hel-
minthes (van Vliet et al. 2005; van Die and Cummings 2010)
and which is present on pituitary hormones, although in this
case it typically bears a 4-sulfate group (Mi et al. 2008). In
addition, MGL binding to the mucin-like domain of ﬁlo-
viruses such as Zaire virus provides a mechanism for entry
into macrophages and dendritic cells (Takada et al. 2004).
Chemical crosslinking indicates that MGL is a homo-trimer
(Iida et al. 1999), but the arrangement of CRDs in the recep-
tor has not been investigated. MGL is formed from a single
type of subunit, which is a Type II transmembrane polypep-
tide in which a C-terminal CRD is separated from the mem-
brane anchor by an extended neck domain (Figure 1A).
In the present work, physical and chemical methods have
been used to show that the extracellular portion of MGL is
a trimer that is stabilized primarily by an almost entirely
helical coiled-coil neck region and that the CRDs form rela-
tively independent domains. The CRDs show speciﬁcity for
GalNAc residues with exposed 3- and 4-hydroxyl groups.
As in the case of serum mannose-binding protein, this com-
bination of selective binding to a simple monosaccharide
epitope and appropriate clustering of binding sites is sufﬁ-
cient to make the receptor a detector for nonself cell
surfaces.
Results and discussion
Characterization of the extracellular portion of MGL
Three isoforms of human MGL, originating from alternative
splicing in the extracellular region, have been described
(Higashi et al. 2002). Compared with isoform 2 (National
Center for Biotechnology Infomation accession number
NP_006335) originally cloned from macrophages (Suzuki
et al. 1996), a form cloned from dendritic cells, which we
designate isoform 3, has a deletion of three amino acids in the
N-terminal portion of the CRD (Figure 1B). A further form,
designated isoform 1 (accession number NP_878910), was
cloned from immature dendritic cells and has an additional in-
sertion of 27 amino acids in the middle of the neck domain
(Valladeau et al. 2001). Screening of tissue cDNA libraries
with polymerase chain reaction primers reveals that the most
common form of mRNA encodes isoform 3.
Portions of MGL isoform 3 corresponding to the whole
extracellular region, as well as subfragments representing the
minimal globular CRD and the CRD with the C-terminal
portion of the neck, were expressed using a bacterial system
in which the protein was renatured from inclusion bodies and
the resulting protein was puriﬁed using afﬁnity chromato-
graphy on galactose-Sepharose. Additional puriﬁcation to
homogeneity was achieved by ion exchange chromatography
(Figure 1C). Cross-linking analysis of the extracellular frag-
ment revealed a clear progression from the monomeric poly-
peptide to a trimer of crosslinked polypeptides at increasing
reagent concentrations (Figure 1D). These results are consist-
ent with cross-linking experiments conducted in cells and
suggest that trimer formation is mediated by regions in the
extracellular portion of the protein. Gel-ﬁltration analysis
revealed an asymmetrical peak, the shape of which suggests
the presence of a dissociating oligomer (Figure 1E). Based on
simple molecular weight calibration of the column, a molecu-
lar weight of 137 kDa was obtained for the main species
present, compared with a predicted value of 77.1 kDa
(3 × 25.7 kDa) for three polypeptides. In combination, these
results are consistent with the presence of a dissociating
trimer that forms an asymmetrical structure due to the pres-
ence of an extended neck or stalk domain together with the
CRDs. The presence of some dissociation for the isolated
extracellular fragment probably reﬂects the absence of the
membrane anchor, which would stabilize the oligomer by
holding the necks in an orientation that favors interactions in
a parallel coiled coil.
Binding properties of MGL
Previous studies of the binding speciﬁcity of MGL employed
artiﬁcial oligomers obtained with Fc fusion domains (van
Vliet et al. 2005). In order to verify the relevance of these
results to the natural trimeric form of the receptor and to take
advantage of the recently enlarged glycan array developed by
the Consortium for Functional Glycomics, a ﬂuorescently
labeled preparation of the extracellular fragment of MGL was
used to probe the array (Figure 2A). Binding to a large
number of oligosaccharides is observed. All but one of the
63 glycans with signals at 2% or higher compared with the
maximal signal share a common feature, which is the presence
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of a GalNAc residue with exposed 3- and 4-hydroxyl groups.
Of the next 12 glycans in rank order of binding, a further
seven meet this criterion and of the remaining 535 glycans on
the array, which score at <0.5% of the maximal value, only
six glycans meet this criterion. A strict requirement for this
pair of exposed hydroxyl groups is consistent with the pro-
posed structure of the ligand complex based on the structure
of the closely related asialoglycoprotein receptor and the CRD
from mannose-binding protein which has been modiﬁed to
mimic the speciﬁcity for GalNAc (Kolatkar et al. 1998;
Feinberg et al. 2000). Binding requires that the 3- and
4-hydroxyl groups ligate to the conserved Ca2+ residue in the
CRD (Figure 2B). Additional contacts with the 2-acetamido
group render binding speciﬁc for GalNAc over galactose.
Among the 75 glycans on the array that contain GalNAc
residues with exposed 3- and 4-hydroxyl groups, other parts
of the glycan structures do not appear to correlate with the ap-
parent strength of binding. Only two oligosaccharides bind
better than a simple GalNAc residue. One of these is the next
simplest structure, the GlcNAcβ1-6GalNAc disaccharide that
Fig. 1. Organization of the MGL polypeptide. (A) A summary of two potential views of MGL organization based on paradigms from mannose-binding protein
(left), in which CRDs interact extensively and DC-SIGN (right), in which the neck regions mediate oligomer formation independently of the CRDs. (B) Linear
diagrams of the MGL polypeptide based on the most abundant isoform, which is designated isoform 3. Additional sequences found in some cDNAs from
alternatively spliced mRNA molecules are present in isoforms 1 and 2. Regions expressed are shown, along with the sequence of the neck region divided into
four sub-regions, which are color-coded to correspond to the sequence above. Two of the sub-regions contain heptad repeat patterns of nonpolar aliphatic amino
acid side chains highlighted with green shading. Glycosylation sites are noted with arrows. The disulﬁde bonding pattern in the CRD is also indicated. (C) SDS–
PAGE (17.5% gel) of puriﬁed fragments of MGL. Left panel, samples without reducing agent. Right panel, samples reduced with 2-mercaptoethanol. Gel was
stained with Coomassie blue. (D) SDS–PAGE (10% gel) of the extracellular fragment of MGL subjected to chemical crosslinking with
bis-sulfosuccinimidylsuberate. Concentrations of cross-linking reagent are indicated at the top of each well. Gel was stained with Coomassie blue. (E)
Gel-ﬁltration analysis of fragments of MGL on a Superdex S200 column. (F) Gel-ﬁltration analysis of CRD and extended CRD of MGL on a Superdex S75
column. In (E and F), elution positions of standards are indicated in kDa at the bottom.
Extracellular portion of the macrophage galactose receptor
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forms the O-linked glycan Core 6, and the top-ranked glycan
contains two different GalNAc residues, either of which could
be accommodated in the binding site. In roughly half the
glycans, the GalNAc residue is exposed as a nonreducing ter-
minal residue while in the remainder it is derivatized on the
6-hydroxyl group. In many cases, the 6-linked sugar is
GlcNAc, but in others sialic acid or sulfate is attached at the 6
position. In the proposed ligand-binding complexes, the 6-
hydroxyl group is projected away from the binding site
(Figure 2B), which is consistent with the ﬁnding that substitu-
tion at this position is tolerated. Similar binding to carbohy-
drates modiﬁed in the 6 position has been reported for hepatic
asialoglycoprotein receptors, although these receptors bind to
galactose-terminated ligands as well (Park and Baenziger
2004; Coombs et al. 2006). Reference to the model in
combination with the glycan array results serves to highlight
the fact that MGL does not just bind to GalNAc residues in
nonreducing terminal positions, since the requirement is for
unmodiﬁed 3- and 4-hydroxyl groups.
In the glycans in which GalNAc is the nonreducing termin-
al residue, there is an approximately equal mixture of ligands
with α- and β-linked GalNAc. This observation is consistent
with the accessibility of the anomeric carbon of the GalNAc
residue in the binding site observed in the structural model
(Figure 2B), so that attachment to hydroxyl groups in either
conﬁguration is possible. There is no clear pattern to the rank
ordering of binding and the presence or absence of speciﬁc
structural features beyond the GalNAc residue. Given that the
simple mono- and disaccharides bind better than other struc-
tures that contain these motifs, the primary effect of various
Fig. 2. Glycan array and pathogen array analysis of MGL-binding speciﬁcity. (A) Synthetic glycan array. Results are arranged in rank order based on decreasing
signal observed on the glycan array probed with ﬂuorescently labeled extracellular fragment of MGL at 10 μg/mL. Similar results were obtained at 1 and 90 μg/
mL. The complete glycan array results are provided in Supplementary data, Table S1. All signals shown in color result from binding of glycans containing
GalNAc with free 3- and 4-hydroxyl groups. In the top 65 glycans, the single exception to this rule is a strong signal for a simple α-linked fucose residue
(Position 7). No studies with MGL binding to earlier versions of the glycan array have revealed binding to this sugar and none of the 170 other glycans on the
array that contain α-linked fucose but lack GalNAc give signals above background, suggesting that this signal does not reﬂect an alternative binding speciﬁcity
for glycans. (B) A model of the binding site of MGL based on the structure of the CRD of mannose-binding protein modiﬁed with portions of the MGL
sequence so that it binds GalNAc (Feinberg et al. 2000). This ﬁgure was prepared with PyMol based on Protein Data Bank entry 1ﬁh. The sequences of the
model protein and human MGL are compared in Supplementary data, Figure S1. (C) Bacterial O-speciﬁc polysaccharide array. Each oligosaccharide is
represented ﬁve times printed directly and ﬁve times printed after derivatization with a disubstituted oxamine linker, each at 0.03, 0.06, 0.125, 0.25 and 0.5 mg/
mL. Red, GalNAc residues in terminal positions on branches; blue, 6-substituted GalNAc in the backbone sequence; green, 3- or 4-substituted GalNAc in the
backbone sequence. A complete list of the bacterial sources of the lipopolysaccharides and their O-speciﬁc polysaccharide core structures is provided in
Supplementary data, Table S2.
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elaborations is to reduce binding, suggesting that in larger
glycans, access of the key hydroxyl groups to the binding site
is reduced as a result of steric hindrance.
The combination of a strict requirement for exposed 3- and
4-hydroxyl groups on GalNAc and a preference for smaller
glycans containing this motif explains the ability of MGL to
bind to the Tn antigen, consisting of GalNAc linked to serine
or threonine residues. The sialyl-Tn structure, NeuAcα2-
6GalNAc, as well as the Core 6 structure also binds. The Tn,
sialyl-Tn and Core 6 structures are all rare on normal cell sur-
faces but particularly the ﬁrst two of these glycans are com-
monly present on cell surface mucins of carcinomas and other
tumor cells (Ju et al. 2008). In contrast, binding to the T
antigen or Core 1 structure, consisting of Galβ1-3GalNAc
linked to serine or threonine residues, is not observed, since
the 3-linked galactose would block binding to the GalNAc
residue. Thus, the simple speciﬁcity deduced from the array
explains the ability of MGL to distinguish normal from tumor
cells and is not necessary to invoke an extended oligosaccharide-
binding site to explain the ability of MGL to bind to tumor
cells.
The binding speciﬁcity observed using the natural trimer
and the expanded synthetic glycan array are consistent with
previous studies using earlier versions of the array containing
more limited sets of glycans and with competition studies
(van Vliet et al. 2005). The glycans on the current array are
presented as oligosaccharides directly linked to coated glass
slides, while the previously reported array employed biotiny-
lated oligosaccharides presented on streptavidin-coated plastic
wells. Thus, the current results demonstrate that the observed
speciﬁcity is platform-independent as well as testing a large
number of glycans that do and do not contain the binding
motif. The ﬁnding that similar glycans are bound regardless
of whether the CRDs are presented in the natural trimer used
here or as part of Fc fusion proteins used in earlier studies
indicates that binding speciﬁcity for individual oligosacchar-
ides arises from contacts with individual CRDs.
Binding of MGL to nonself glycans
The array of synthetic glycans generated by the Consortium
for Functional Glycomics contains only a limited number of
sugar combinations commonly found on bacterial pathogens,
although it does contain glycans with terminal GalNAcβ1-
4GlcNAc (LacdiNAc) disaccharides that are commonly found
on helminthes. To investigate the ability of MGL to interact
with nonself glycans on micro-organisms, the same prepar-
ation of labeled, trimeric extracellular fragment was used to
probe a prototype pathogen array, which contains 48 terminal
oligosaccharide structures from bacterial outer membrane lipo-
polysaccharides. The results reveal a strong signal with a
single oligosaccharide and much weaker signals for three
other oligosaccharides (Figure 2C). These results are fully
consistent with the proposed speciﬁcity based on the synthetic
array. The strong signal arises from binding to the terminal
GalNAc residues present on the repeated branches of the
oligosaccharide from Proteus mirabilis O29a/O29b. The
weaker signal for the oligosaccharide from P. mirabilis O3a/
O3c reﬂects the presence of two GalNAc residues in the back-
bone, one of which would be a potential ligand if branches
were absent from the 4 position in some copies of the repeat
unit. The other GalNAc residue in this oligosaccharide as
well as the GalNAc residues in the backbone sequences of
Providencia alcalifaciens O21 and Pseudomonas aeruginosa
O15 would not be expected to bind to MGL, since they are
substituted at the 3- or 4-position. However, some copies of
the oligosaccharide will have a single terminal GalNAc
residue, so there will be a limited number of sites for binding
to MGL. The frequency of such residues, at most one per
oligosaccharide molecule, is much less than for the frequency
of branches in the P. mirabilis O3a/O3c oligosaccharide,
leading to weaker binding. There are other oligosaccharides
on the array that contain backbone GalNAc residues, but
these occur at only one position in longer repeats, while
GalNAc makes up between 50 and 75% of the residues in the
three oligosaccharides that show weak binding, resulting in a
predicted higher frequency of exposed terminal GalNAc resi-
dues in these cases.
The strong selectivity of human MGL for GalNAc contrasts
with the comparable binding of both galactose- and
GalNAc-terminated structures by the single rat ortholog of
human MGL (Iobst and Drickamer 1996; Coombs et al.
2006). Of the two mouse orthologs, one shows binding to
both galactose and GalNAc, with preferential binding to
GalNAc and the other is largely speciﬁc for oligosaccharides
containing Lewisa or Lewisx epitopes (Tsuiji et al. 2002;
Singh et al. 2009). Such variation in the binding speciﬁcity of
glycan-binding receptors between species seems to be more
common for receptors that bind pathogens, such as DC-SIGN,
compared with those that bind endogenous ligands, such as
the selectins (Powlesland et al. 2006).
Cluster of binding sites generated by trimer formation in the
neck region
The conﬁrmation that the binding epitope is relatively simple
is analogous to the ﬁnding that mannose-binding protein
binds to terminal sugar residues that have free 3- and
4-hydroxyl groups with the stereochemistry found in mannose
and GlcNAc. In the same way that mannose-binding protein
binds to bacterial and fungal walls because of the presence of
high concentrations of these target sugars, it seems likely that
MGL binds to pathogens and tumor cells largely as a result of
the presence of high concentrations of appropriately exposed
GalNAc rather than a more speciﬁc structure.
Based on the similar ways that MGL and mannose-binding
protein each bind a simple epitope common on target cells
but rare on endogenous cells, the relative positioning of
binding sites in MGL may be an important determinant of
biological targets as it is in MBP. The structural basis for for-
mation of the oligomers was investigated by comparing the
extracellular fragment of MGL and CRD-containing frag-
ments (Figure 1E and F). Gel-ﬁltration analysis of the CRD
and the extended CRD yielded molecular weight values corre-
sponding closely to the expected values for globular polypep-
tides of 18 and 20 kDa, respectively. These results, combined
with the earlier analysis of the full extracellular fragment of
the polypeptide, indicate that the neck region of the protein is
required for oligomer formation.
Extracellular portion of the macrophage galactose receptor
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N-terminal to the ﬁrst cysteine residue that deﬁnes the
minimal CRD (Figure 1B), the sequence of much of the neck
contains aliphatic amino acid side chains arranged in heptad
repeats that are characteristic of α-helical coiled coils.
However, the heptad repeat pattern is not evident in the
N-terminal 20 amino acid residues of the neck, and there is
an interruption in the middle of the neck. In order to investi-
gate the conformation of the neck domain in the extracellular
fragment of MGL by circular dichroism analysis, it was ne-
cessary to subtract the spectrum of the CRD from larger frag-
ments (Figure 3A and B). An unusual feature of the CD
spectrum is a region of positive ellipticity at 229 nm followed
by a negative inﬂection at 235 nm. Signals at this wavelength
are generally associated with amino acid side chains, particu-
larly the indole ring of tryptophan, interacting with backbone
amides (Liang and Chakrabarti 1982; Woody 1994). A key
conserved tryptophan residue in C-type CRDs lies under the
sugar-binding Ca2+ site, packed against an unusual cis-proline
residue that is ﬂanked by two of the ligands for the Ca2+ (Ng
et al. 1998; Ng and Weis 1998). In mannose-binding protein,
the conﬁguration of this proline residue changes in the
absence of Ca2+ and it moves away from the tryptophan
residue (Ng et al. 1998; Ng and Weis 1998). Titration of the
CRD with Ca2+ revealed a change in the signal at 229 nm
which occurs with a midpoint for the transition at 0.2 mM
Ca2+ (Figure 3C and D), which corresponds to the concentra-
tion range for Ca2+ binding as assessed by the Ca2+-
dependence of ligand binding to C-type CRDs (Loeb and
Drickamer 1988; Weis et al. 1991). The sensitivity of the CD
signal in this region of the spectrum is thus consistent with a
model for the structure of the CRD from MGL based on the
CRD of mannose-binding protein, in which the CD signal of
the conserved tryptophan is sensitive to the position and con-
formation of the proline residue.
The difference circular dichroism spectra of the CRD and
the full extracellular fragment yielded a spectrum correspond-
ing closely to >98% α-helical spectrum based on CDNN de-
convolution analysis (Figure 3A). The lower trough at 222
nm compared with 208 nm is expected for a coiled coil com-
pared with a simple helical structure (Monera et al. 1993). A
similar analysis of the extended CRD compared with the
CRD revealed that the region of the neck adjacent to the
CRD is also largely helical even in the absence of the re-
mainder of the neck (Figure 3B). The results conﬁrm that, in
spite of the irregularities in the heptad repeats, the neck
region extends all the way to the base of the CRD deﬁned
by the ﬁrst cysteine residue that is involved in disulﬁde
bonding within the CRD.
Fig. 3. Conformations of MGL fragments analyzed by circular dichroism. Circular dichroism spectra for the entire extracellular fragment of MGL and for the
CRD and extended CRD fragments were normalized on a molar basis so that difference spectra corresponding to the neck could be obtained by subtraction. (A)
Calculation of difference spectrum corresponding to the entire neck domain. (B) Calculation of difference spectrum corresponding to portion of the neck adjacent
to the CRD. (C) Circular dichroism spectrum of the CRD as a function of Ca2+ concentration. (D) Ca2+-dependence of circular dichroism of the CRD at 229 nm.
Values for the molar ellipticity at 229 nm were ﬁtted to a third-order binding equation using SigmaPlot.
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Relationship between domains in the extracellular portion
of MGL
To examine the relationship between the neck domain and the
CRDs, limited proteolysis was employed to probe for structur-
ally discrete regions of MGL. In earlier studies of mannose-
binding protein, subtilisin was used to deﬁne exposed regions
of the polypeptide because of the relatively broad speciﬁcity
of the protease (Weis et al. 1991). Digestion of MGL under
similar conditions resulted in rapid digestion to low molecular
weight fragments (Figure 4). Compared with the CRD of
mannose-binding protein, the CRD of MGL contains an extra
glycine-rich loop extending from the surface of the protein,
which forms a key part of the galactose-binding site (Kolatkar
et al. 1998). Thus, it seems likely that digestion by subtilisin
in this extended loop structure results in degradation of the
CRD and it was necessary to employ trypsin to screen for
protease-sensitive sites elsewhere in the extracellular fragment
of MGL. Trypsin would not be expected to cut within this
loop because it lacks basic residues (Figure 4). The results
reveal that the predominant cleavage results in a stable frag-
ment corresponding to the CRD, indicating that the junction
between the CRD and the neck is more protease-sensitive
than other regions of the polypeptide. Alternatively, the
results might reﬂect lower stability of the neck region, which
might partially unfold and become sensitive to proteases
while the CRD remains protease resistant.
Differential scanning calorimetry was used to determine the
extent to which the neck and CRD of MGL fold and function
independently. Two transitions were observed upon heating of
the intact extracellular fragment of MGL, one centered at 45°
C and one at 62°C (Figure 5A). Based on results with other
C-type CRDs, the denaturation temperature near 62°C would
be expected to represent the CRD (Yu et al. 2009), a predic-
tion that was conﬁrmed by analysis of the CRD and the
extended CRD by calorimetry (Figure 5B and C), each of
which shows a single transition at approximately 62°C. Thus,
the lower temperature transition was predicted to correspond
to unfolding of the neck. The presence of two transitions
would be consistent with the neck and CRD behaving as
largely independent domains. This interpretation is supported
by the fact that the CRD denatures at the same temperature in
isolation as it does in the presence of the neck region.
Fig. 4. Limited proteolysis of the extracellular fragment of MGL. SDS–PAGE of digestions conducted for 30 min at 37°C at increasing concentrations of
protease. Gel was stained with Coomassie blue. The bacterially expressed CRD fragment of MGL was run in parallel for comparison in the ﬁnal lane of the
left-hand panel.
Fig. 5. Stability of MGL fragments analyzed by differential scanning
calorimetry. Proteins were extensively dialyzed against 100 mM NaCl,
10 mM HEPES, pH 7.4 and 2.5 mM CaCl2 for calorimetry. Concentrations of
proteins were (A) extracellular fragment of MGL 2.7 mg/mL; (B) extended
CRD, 0.7 mg/mL; (C) CRD, 10.0 mg/mL.
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Further evidence regarding the stabilities of the two
domains in the extracellular portion of MGL was obtained by
examining the effect of temperature on the circular dichroism
spectrum. Comparing the circular dichroism signal at 229 nm
for the isolated CRD at various temperatures produced a de-
naturation curve with a midpoint of unfolding falling at 67°C,
which is consistent with the value obtained from the calorim-
etry experiments (Figure 6A and B). In contrast, analysis of
the signal at 222 nm for the spectrum of the intact extracellu-
lar fragment of MGL, which is dominated by the signal from
the α-helical neck domain, gave a transition temperature of
34°C (Figure 6C and D). These results are consistent with the
interpretation that the lower temperature transition in the cal-
orimetry experiments corresponds to denaturation of the neck
as a transition independent of the unfolding of the CRD.
Corresponding to the two-step unfolding process, cooling of
the denatured sample resulted in two-step renaturation, a cycle
that could be repeated (data not shown). This stepwise revers-
ibility is also consistent with the presence of independent
domains.
The neck domain of MGL as an oligomerization domain
To complement the experiments comparing the effect of re-
moving the neck from the CRD, the neck domain was studied
in isolation. The neck polypeptide was expressed with a
C-terminal His6 sequence in place of the CRD, which allowed
puriﬁcation on immobilized Ni2+ in the presence of urea and
detection by western blotting (Figure 7A, lanes 1 and 2). The
polypeptide was eluted efﬁciently with 100 mM imidazole.
Following removal of the denaturing agent, the renatured neck
polypeptide was re-puriﬁed on immobilized Ni2+. In this case,
release of the protein from the resin required overnight incu-
bation in the presence of ethylenediaminetetraacetic acid
(EDTA), presumably reﬂecting the presence of a large cluster
of histidine residues in the re-formed oligomer (Figure 7A,
lane 3). Gel-ﬁltration analysis revealed that the isolated neck
polypeptide was present largely as an oligomer that eluted at
an apparent molecular weight of 38 kDa (Figure 7B). As with
the extracellular fragment, this value is larger than the
expected molecular weight of 29.8 kDa for a trimer, which
would reﬂect the extended nature of the polypeptide. The
shape of the elution proﬁle suggests an equilibrium with a
small form, which would correspond to the monomeric neck
as in the case for the full extracellular fragment of the
receptor.
The circular dichroism spectrum of the isolated neck
domain is dominated by α helix (Figure 7C). As the concen-
tration of the protein is decreased, the ratio of molar ellipticity
at 222 compared with 208 decreases slightly, consistent with
Fig. 6. Stability of MGL fragments analyzed by circular dichroism. (A and B) Folded conformation of the CRD (0.07 mg/mL) was assessed by comparing the
molar ellipticity at 229 nm, which reﬂects the folded conformation of the tryptophan residue adjacent to the Ca2+ that forms the sugar-binding site (see Figure 3C
and D). (C and D) Folded conformation of the neck domain (0.27 mg/mL) was assessed based on the ellipticity at 222 nm of the extracellular fragment of MGL,
which is sensitive to the α-helical conformation that arises dominantly from the neck domain. Proteins were dialyzed extensively against 10 mM Tris-Cl, pH 7.4
and 2.5 mM CaCl2. Spectra represent averages of 10 scans each, taken after a 2-min stabilization period at each temperature. Data were ﬁtted to ﬁrst order
transitions in order to determine the midpoint of the unfolding transitions.
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the suggestion that the coiled coil is partially dissociating.
These results correspond to the conformation observed in the
difference spectrum for the neck obtained by comparing the
isolated CRD and entire extracellular fragment of the protein
(Figure 3A). Thus, the neck assumes an α-helical conform-
ation independently of the CRDs. Differential scanning calor-
imetry analysis of the neck domain yielded a single
denaturation event centered at approximately 45°C
(Figure 7D). This value closely matched the deduced value
for the neck in the context of the entire extracellular portion
of the polypeptide. Taken together, the gel ﬁltration, calorim-
etry and circular dichroism data indicate that the neck domain
of MGL functions as a coiled-coil α-helical oligomerization
domain that is necessary and sufﬁcient for formation of recep-
tor trimers.
The ﬁnding that the neck domain is primarily responsible
for trimer formation contrasts with mannose-binding protein,
in which extensive interactions between the CRDs are needed
to stabilize the trimer and the neck domain is too short to
form a stable coiled coil on its own. The ability of the neck to
form a trimer in the absence of the CRDs is more like the
situation with DC-SIGN, in which the neck is a fully inde-
pendent trimerization domain. The analogy with DC-SIGN,
as well as the ﬁnding that the neck-CRD junction is protease
sensitive, suggests that the CRDs may be ﬂexibly positioned
so that their positions can adjust to accommodate the pattern
of glycans on cell surfaces.
Conclusion
The analysis presented here indicates that the mechanism of
target recognition by MGL shares features with both serum
mannose-binding protein and DC-SIGN. Like mannose-
binding protein, MGL has a monosaccharide-speciﬁc binding
site that interacts with a simple epitope, which is characteristic
of nonself oligosaccharides. As with DC-SIGN, the clustering
of these binding sites is achieved through an independent
oligomerization domain that may provide some ﬂexibility in
the positioning of the binding sites. Interestingly, recent struc-
tural analysis of langerin indicates that it combines a different
set of features, in which there are extensive interactions
between the CRDs, forming a ﬁxed cluster as in mannose-
binding protein, but the individual binding sites are more
extended, as in DC-SIGN, leading to more selective ligand
binding (Feinberg, Powlesland et al. 2010).
Methods
Cloning of MGL fragments
The extracellular fragment of MGL was cloned from a human
liver cDNA library using Advantage II polymerase (Takara,
St-Germain-en-Laye, France) with ﬂanking primers TGGCCA
ATTCCAAATTTCAGAGGGACCTGGTGACC (forward) and
CCGGGTGGTCCCACCAAAGGCAGCTCAGTG (reverse).
Products of the polymerase chain reaction were cloned into
Fig. 7. Puriﬁcation and analysis of the neck domain of MGL. (A) SDS–PAGE (17.5% gel) of neck domain puriﬁed on immobilized Ni2+ in the presence of urea
(lane 1, Coomassie blue; lane 2, detection with antibody to the His6 tag) and following further puriﬁcation on immobilized Ni
2+ in the absence of urea (lane 3,
Coomassie blue). (B) Gel-ﬁltration analysis of the neck domain of MGL on a Superdex S75 column. Concentrations of starting samples (100 μL) are indicated.
(C) Conformation of the neck domain analyzed by circular dichroism. (D) Stability of the neck domain determined by differential scanning calorimetry. Protein
concentration was 0.65 mg/mL.
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vector pCRII-TOPO (Invitrogen, Paisley, UK). Fragments for
expression were ampliﬁed from this cDNA, using primers to
insert into the T7 expression vector pT5T (Eisenberg et al.
1990; Iobst and Drickamer 1996). The N-terminal sequences
of the expressed fragments were: (Ala)AsnSerLysPheGln for
the extracellular fragment, (Ala)AlaValHisSer for the extended
CRD and AlaLeuThrCysGlnVal for the CRD. For the neck
domain, a reverse primer encoding the C-terminal end of the
neck domain and the His6 tag resulted in a C-terminal se-
quence of AspLeuLysLysLeuGlyHisHisHisHisHisHis. The
expression plasmids were transformed into Escherichia coli
strain BL21/DE3 for production of protein.
Preparation of CRD-containing fragments of MGL
Extracellular fragment and CRD-containing fragments were
produced as inclusion bodies in E. coli, extracted, refolded
and puriﬁed by afﬁnity chromatography on galactose-
Sepharose (Fornstedt and Porath 1975) as previously
described (Iobst and Drickamer 1996) using loading buffer
consisting of 0.5 M NaCl, 25 mM Tris-Cl, pH 7.8, and 25
mM CaCl2 and eluting buffer consisting of 0.5 M NaCl, 25
mM Tris-Cl, pH 7.8, and 2.5 mM EDTA. The fragment corre-
sponding to the extracellular portion of the protein was further
puriﬁed by gel ﬁltration on a 1 × 30 cm Superdex-200 column
(GE Healthcare Life Sciences, Little Chalfont, UK) in the
presence of 6 M urea, 25 mM Tris-Cl, pH 6.8, at a ﬂow rate
of 1 mL/min. Absorbance was monitored at 280 nm and on
17.5% sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS–PAGE) run in the absence of reducing agent.
Fractions containing monomeric fragments lacking inter-chain
disulﬁde bonds were pooled and renatured by dialysis against
150 mM NaCl, 25 mM Tris-Cl, pH 7.8, 25 mM CaCl2. For re-
puriﬁcation of the CRD and extended CRD, the proteins were
dialyzed against 50 mM Tris-Cl, pH 7.8, and centrifuged at
100,000 × g at 4°C for 15 min before fractionation on a 1-mL
MonoQ column (GE Healthcare Life Sciences). The column
was eluted with a linear gradient from 0 to 0.5 M NaCl in 50
mM Tris-Cl, pH 7.8, and fractions containing puriﬁed frag-
ments were identiﬁed by SDS–PAGE. The CRD eluted at
0.25 M NaCl and the extended CRD eluted at approximate-
ly 0.4 M NaCl.
Preparation of MGL neck domain
Luria-Bertani medium (3 × 1 L) containing 50 μg/mL ampicil-
lin was inoculated with 3 × 30 mL of an overnight culture that
had been grown at 25°C. The culture was grown, with shaking,
at 37°C to an OD550 of 0.8, at which point is was induced with
100 μg/mL isopropyl β-D-thiogalactopyranoside and incubated
for a further 2.5 h at 37°C with shaking. Cells were harvested
by centrifugation at 4000 × g at 4°C for 15 min, resuspended in
30 mL of cold 10 mM Tris-Cl, pH 7.8, buffer, and centrifuged
at 10,000 × g at 4°C for 10 min. The supernatants were dis-
carded and the pelleted cells were kept frozen at −80°C. For
puriﬁcation of the neck domain, the pellet was thawed and sus-
pended in 60 mL of cold N1 buffer (0.5 M NaCl 25 mM
Tris-Cl, pH 7.8) and lysed by sonication (4 bursts of 30 s dur-
ation). The lysate was centrifuged at 20,000 × g for 15 min at
4°C. Solid urea (28.8 g) was added to bring the solution to 8 M
urea. Following centrifugation at 100,000 × g in a Beckman
50.2 Ti rotor for 30 min at 4°C, the supernatant was passed
over a 2-mL NTA agarose column (QIAGEN, Manchester,
UK) preloaded with 10 mL of 50 mM NiSO4 and equilibrated
in N1 buffer at room temperature. The column was washed
with 10 mL of 0.5 M NaCl, 25 mM Tris-Cl, pH 8.0, and 8 M
urea with 20 mM imidazole and eluted with 3 column volumes
each of N1 buffer containing 8 M urea and 50 mM, 100 and
200 mM imidazole. Following analysis on a 17.5% SDS–
PAGE, fractions containing the neck domain, eluting at 100
mM imidazole, were dialyzed against N1 buffer and repuriﬁed
on a 2-mL Ni2+-NTA agarose column in the absence of urea.
The column was rinsed with 10 mL of N1 buffer containing
20 mM imidazole and eluted with 3 column volumes each of
N1 buffer containing 50, 100 and 200 mM imidazole, followed
by 6 × 1 mL of N1 buffer containing 10 mM EDTA. The
column was kept overnight at 4°C and the tightly bound
protein was eluted with an additional 8 × 1 mL of N1 buffer
containing 10 mM EDTA. Puriﬁcation was monitored by
SDS–PAGE on 17.5% gels (Laemmli 1970). Western blots
(Burnette 1981) were developed with mouse anti-His6 antibody
(Sigma Chemical Co., Dorset, UK) followed by goat anti-
mouse IgG coupled to alkaline phosphatase (Jackson
ImmunoResearch, West Grove, PA) and developed using nitro-
blue tetrazolium and 5-bromo-4-chloro-3′-indolylphosphate.
Gel-ﬁltration analysis
Gel-ﬁltration analysis was performed on 1 × 30 cm Superdex-
75 and 200 columns (GE Healthcare Life Sciences). For extra-
cellular and CRD fragments, columns were eluted with 10 mM
Tris-Cl, pH 7.8, 100 mM NaCl and 2.5 mM EDTA at a ﬂow
rate of 0.5 mL/min and absorbance was monitored at 280 nm.
In order to allow monitoring at 214 nm, EDTA was omitted
from the elution buffer for samples of the neck domain frag-
ment and the column was eluted in 0.5 M NaCl, 10 mM
Tris-Cl, pH 7.8. Data were collected and processed using the
UNICORN software. Elution positions of the following stand-
ard proteins (with Mr as indicated) were determined: Aprotinin
(6.5 kDa), cytochrome c (12.4 kDa), bovine erythrocyte carbon-
ic anhydrase (29 kDa), ovalbumin (43 kDa), bovine serum
albumin (67 kDa), yeast alcohol dehydrogenase (141 kDa),
β-amylase (200 kDa), E. coli β-galactosidase (464 kDa) and
thyroglobulin, (670 kDa). The void volume was determined
using dextran blue and the salt volume was determined from the
elution position of salt in the sample detected by conductivity.
Glycan array analysis
The extracellular fragment of MGL (250 µg) was repuriﬁed
on a 1-mL column of galactose-Sepharose. After washing with
5 mL of 125 mM NaCl, 100 mM Na-bicine, pH 9.0, 25 mM
CaCl2, the protein was eluted in 0.5-mL aliquots with 125 mM
NaCl, 100 mM Na-bicine, pH 9.0, 2.5 mM EDTA. The peak
fractions adjusted to 25 mM CaCl2 and 25 µg of ﬂuorescein
isothiocyanate was added as 5 aliquots of 5 µL dissolved at
1 mg/mL in dimethyl sulfoxide. After incubation overnight at
4°C, the protein was repuriﬁed by afﬁnity chromatography on a
1-mL column of galactose-Sepharose following the above
protocol but using 125 mM NaCl, 25 mM Tris-Cl, pH 7.8, 25
mM CaCl2 loading buffer and 125 mM NaCl, 25 mM Tris-Cl,
pH 7.8, 2.5 mM EDTA elution buffer. Version 5.1 of the
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synthetic glycan array of the Consortium for Functional
Glycomics was screening by the standard protocol (Blixt et al.
2004; Feinberg, Taylor et al. 2010). Preparation of the proto-
type pathogen glycan array, containing bacterial polysacchar-
ides, is summarized in Feinberg, Taylor et al. (2010), and
details are available at: www.functionalglycomics.org/static/
consortium/resources/timelined2p.shtml (McBride et al., in
preparation). The synthetic array was screened at 1, 10 and
90 μg/mL of labeled protein and the pathogen array was
screened at 90 μg/mL.
Limited proteolysis
Proteolysis with subtilisin or trypsin was performed in 0.5 M
NaCl, 25 mM Tris-Cl, pH 7.8, 25 mM CaCl2. Aliquots (20 µL)
of the extracellular fragment of MGL were combined with
freshly prepared trypsin or subtilisin solutions and incubated 1
h at 37°C. Proteolysis was stopped by the addition of 20 µL of
2× SDS–PAGE sample buffer, followed by immediate boiling
for 5 min and analysis on 17.5% polyacrylamide gels.
Crosslinking
The extracellular fragment of MGL was re-puriﬁed by afﬁnity
chromatography on a 1-mL galactose-Sepharose column that
was washed with 5 mL of 125 mM NaCl, 100 mM HEPES,
pH 7.8, 25 mM CaCl2 and eluted with 0.5-mL aliquots of
125 mM NaCl, 100 mM HEPES, pH 7.8, 2.5 mM EDTA.
CaCl2 was added to a ﬁnal concentration of 10 mM to the
peak fraction, which contained 250 μg/mL protein. Aliquots
(25 μL) were incubated with bis(sulfosuccinimidyl)suberate
(Thermo Scientiﬁc, Hemel Hempstead, UK) for 1 h at room
temperature. Reactions were stopped by adding 2 × sample
buffer containing 1% 2-mercaptoethanol and were immediate-
ly analyzed on a 10% SDS–PAGE.
Circular dichroism analysis
Samples were dialyzed against 25 mM NaCl, 5 mM Tris-Cl,
pH 7.8, 2.5 mM CaCl2 and analyzed at 0.1–0.2 mg/mL ﬁnal
concentration. For the Ca2+ titration, the sample was dialyzed
against 25 mM NaCl, 5 mM Tris-Cl, pH 7.8, after which CaCl2
was added from a 1 M stock to achieve the indicated ﬁnal con-
centrations. Circular dichroism spectra on 200 µL samples
were obtained in a 1-mm quartz cell using a Chirascan spectro-
polarimeter (Applied Photophysics, Leatherhead, UK) at a
band width of 1 nm, step size of 0.5 nm and 1 s per step. The
spectra presented represent an average of ten scans.
Denaturation was monitored by performing scans at intervals
of 5°C, after equilibration for 2 min at each temperature. Data
were ﬁtted to a simple ﬁrst-order curve using SigmaPlot.
Protein concentrations were determined by the alkaline ninhyd-
rin assay (Hirs 1967).
Differential scanning calorimetry
Samples were dialyzed extensively against 25 mM Na-HEPES,
pH 7.8, 125 mM NaCl, 5 mM CaCl2 and degassed for 15 min.
Analysis was performed in a Calorimetry Sciences Nano III
calorimeter with a sample loop volume of 300 μL. Initial scans
from 5 to 20°C were repeated until a stable signal was
obtained. Baselines were calculated using a third-order
polynomial equation to ﬁt the data using SigmaPlot as previ-
ously described (Wallis et al. 2004). Protein concentrations
were determined by the alkaline ninhydrin assay (Hirs 1967).
Supplementary data
Supplementary data for this article are available online at http://
glycob.oxfordjournals.org/.
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